IRIS
SAMBATARO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.966
AS - Asia 1.567
SA - Sud America 558
EU - Europa 395
AF - Africa 41
OC - Oceania 1
Totale 5.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.872
SG - Singapore 598
BR - Brasile 463
HK - Hong Kong 390
CN - Cina 158
VN - Vietnam 138
IT - Italia 107
BD - Bangladesh 97
IE - Irlanda 81
TR - Turchia 51
DE - Germania 42
MX - Messico 38
GB - Regno Unito 36
FR - Francia 35
CA - Canada 33
AR - Argentina 32
IN - India 32
PL - Polonia 21
ID - Indonesia 20
CO - Colombia 17
EC - Ecuador 16
ZA - Sudafrica 16
RU - Federazione Russa 15
ES - Italia 12
IQ - Iraq 11
JP - Giappone 11
SA - Arabia Saudita 11
NL - Olanda 10
UA - Ucraina 9
PY - Paraguay 8
MA - Marocco 7
VE - Venezuela 7
AT - Austria 6
EG - Egitto 6
HN - Honduras 6
PK - Pakistan 6
UZ - Uzbekistan 6
CL - Cile 5
KZ - Kazakistan 5
MY - Malesia 5
PE - Perù 5
PH - Filippine 5
SE - Svezia 5
FI - Finlandia 4
QA - Qatar 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
ET - Etiopia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 5.528
Salva come PNG Salva come JPEG
Città #
Dallas 1.375
Hong Kong 389
San Jose 359
Singapore 287
Ashburn 218
Santa Clara 134
Chicago 122
The Dalles 121
Dublin 81
Beijing 55
Ho Chi Minh City 50
New York 46
Istanbul 39
São Paulo 30
Hanoi 29
Los Angeles 29
Hillsboro 22
Assago 20
Mexico City 20
Warsaw 19
Rio de Janeiro 17
Montreal 14
Council Bluffs 12
Rome 11
Belo Horizonte 10
San Francisco 10
Tokyo 10
Düsseldorf 9
Johannesburg 9
Toronto 9
Brasília 8
Frankfurt am Main 8
Manchester 8
Porto Alegre 8
Biên Hòa 7
Brooklyn 7
Buffalo 7
Catania 7
Curitiba 7
Milan 7
Seattle 7
Chennai 6
Dhaka 6
Hải Dương 6
London 6
Manaus 6
Medellín 6
Palermo 6
Thái Bình 6
Ankara 5
Atlanta 5
Charlotte 5
Denver 5
Guayaquil 5
Jeddah 5
Lima 5
Limburg an der Lahn 5
Limeira 5
Maceió 5
Nova Iguaçu 5
Phoenix 5
Reston 5
Thái Nguyên 5
Asunción 4
Baghdad 4
Boston 4
Camaçari 4
Campinas 4
Caxias do Sul 4
Doha 4
Fortaleza 4
Helsinki 4
Jakarta 4
Lauterbourg 4
Naples 4
Salvador 4
Santo André 4
Stockholm 4
São Bernardo do Campo 4
Tashkent 4
Addis Ababa 3
Araraquara 3
Bogotá 3
Buenos Aires 3
Cape Town 3
Caracas 3
Cariacica 3
Casablanca 3
Cuiabá 3
Da Nang 3
Florence 3
Franca 3
Joinville 3
Lahore 3
Ludhiana 3
Miami 3
Mogi das Cruzes 3
Montevideo 3
Moscow 3
Mumbai 3
Totale 3.883
Salva come PNG Salva come JPEG
Nome #
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 83
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 80
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 79
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project 68
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 68
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 67
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 66
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 66
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 65
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 63
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 63
COVAD survey 2 long-term outcomes: unmet need and protocol 61
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 60
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 60
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 59
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 58
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 58
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group 57
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 57
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project 57
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 57
Autoimmunity in interstitial lung disease 57
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 55
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study 55
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 55
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 54
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 54
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 53
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 53
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 53
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 53
A die-hard giant capillary 52
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 52
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply 52
Pulmonary vasculitides: A radiological review emphasizing parenchymal hrct features 52
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 51
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 50
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course 50
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 50
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 50
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 49
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 49
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 49
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 48
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 48
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 47
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 47
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 46
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey 46
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 46
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 46
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 46
Quantitative evaluation of fibrosis in ipf patients: Meaning of diffuse pulmonary ossification 45
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 45
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 45
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 44
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: A comparative analysis of the COVAD surveys 44
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 43
Developing PI3K Inhibitors for Respiratory Diseases 43
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 43
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 42
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 42
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 42
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 42
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 42
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 42
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 41
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 40
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 40
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 40
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? 39
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 39
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? 39
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome 39
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 39
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 39
Hepatic PPARs: Their role in liver physiology, fibrosis and treatment 38
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 38
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 38
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 37
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 37
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: Results from the COVAD study 37
Eosinophilic Interstitial Pneumonia 36
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 36
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 36
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 36
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 35
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 35
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys 35
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 35
COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19 35
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 35
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 35
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation 35
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 34
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study 34
Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss 34
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 34
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives 33
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 33
Totale 4.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.523 0 0 0 0 334 287 113 127 156 189 203 114
2025/20264.163 214 941 699 543 69 144 325 318 380 297 212 21
Totale 5.686